# Janssen Pharmaceutica, N.V. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/janssen-pharmaceutica-nv/7ed39763-06a4-46b7-a9a1-76399c53844c

> Inspection records and compliance data for Janssen Pharmaceutica, N.V. in Beerse, None. Access full analysis and detailed observations.

---

## Details

- Name: Janssen Pharmaceutica, N.V.
- FEI Number: 3002807336
- City: Beerse
- State: None
- Country Name: Belgium
- Address Line 1: Turnhoutseweg 30
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1290376 - Janssen Pharmaceutica, N.V. - 2025-11-21](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/95b64378-3420-419d-8d41-960f9de3a664) — source: FDA, date: November 21, 2025
- [FDA Inspection 1290376 - Janssen Pharmaceutica, N.V. - 2025-11-21](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/957319c1-7998-4d12-b0fd-5562e3f4a6af) — classification: No Action Indicated (NAI), source: FDA, date: November 21, 2025
- [FDA Inspection 1290376 - Janssen Pharmaceutica, N.V. - 2025-11-21](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/01fcb5e2-bb69-43d5-bac3-e16af098fc92) — classification: No Action Indicated (NAI), source: FDA, date: November 21, 2025
- [483 - Janssen Pharmaceutica, N.V. - 2025-09-05](https://www.globalkeysolutions.net/records/483/janssen-pharmaceutica-nv/6c8e1b3c-df77-49af-9a7b-08fc5cf52d66) — source: FDA, date: September 5, 2025
- [FDA Inspection 1270321 - Janssen Pharmaceutica, N.V. - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/32ca5402-5a1e-4e6e-9991-e79d82352d96) — source: FDA, date: September 5, 2025
- [FDA Inspection 1270321 - Janssen Pharmaceutica, N.V. - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/869c453e-65da-4ce1-9c4d-40fc68e49d7b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 5, 2025
- [FDA Inspection 1296030 - Janssen Pharmaceutica, N.V. - 2025-05-12](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/005b8060-f291-4f48-a9e2-d7a9d9f473a0) — source: FDA, date: May 12, 2025
- [FDA Inspection 1296030 - Janssen Pharmaceutica, N.V. - 2025-05-12](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/d383b72b-61f6-4b3c-a86d-af5fb1735d05) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 12, 2025
- [FDA Inspection 1203728 - Janssen Pharmaceutica, N.V. - 2021-07-02](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/f0d3199e-6d0e-4403-90ea-e38b4ab27899) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 2, 2021
- [FDA Inspection 1055920 - Janssen Pharmaceutica, N.V. - 2018-06-12](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/e54555d0-cf11-4c2b-95a8-8722099e9c5f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 12, 2018
- [FDA Inspection 964766 - Janssen Pharmaceutica, N.V. - 2016-03-01](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceutica-nv/d43ea0e0-e75a-48b4-8c78-2e242959c8fc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 1, 2016

## Related Companies

- [Noxell Corporation](https://www.globalkeysolutions.net/companies/noxell-corporation/0c12f714-89cc-48e4-92fc-1726842646d2)
- [LGM Pharma Solutions, LLC](https://www.globalkeysolutions.net/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19)
- [L. Perrigo Company](https://www.globalkeysolutions.net/companies/l-perrigo-company/33abbe15-b6ff-4a2b-a8bb-563cb2a55d49)
- [Frontida BioPharm Inc](https://www.globalkeysolutions.net/companies/frontida-biopharm-inc/dc8190f9-0e13-4160-a611-dcf664f43b09)
- [Ferndale Laboratories, Inc.](https://www.globalkeysolutions.net/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)
- [Prime Matter Labs](https://www.globalkeysolutions.net/companies/prime-matter-labs/dddd6753-e267-4dbe-af3e-69350e9aab1c)
- [Nostrum Laboratories Inc](https://www.globalkeysolutions.net/companies/nostrum-laboratories-inc/413bfa94-38e9-443d-a6fd-f3028c7156bf)
- [Genzyme Corporation](https://www.globalkeysolutions.net/companies/genzyme-corporation/a58b7a37-69a3-45d1-a590-72294e5e7a17)
- [Jianerkang Medical Co., Ltd](https://www.globalkeysolutions.net/companies/jianerkang-medical-co-ltd/4cd5cca8-7e53-45e0-9fe5-42981a741cd0)
- [Becton Dickinson Infusion Therapy Systems, Inc.](https://www.globalkeysolutions.net/companies/becton-dickinson-infusion-therapy-systems-inc/d0e73e32-eca1-4137-8dfc-d6bde32ba0aa)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/ruben-c-ayala/6b5dadad-56b8-4af0-a65f-4685f71f0c8d)
- [Xingfang Li](https://www.globalkeysolutions.net/people/xingfang-li/ba1d0660-b34d-4acf-bd63-e5c7c9c2f8cb)